DIAMEDICA THERAPEUTICS INC (DMAC): Institutional Ownership

Hedge funds and institutional managers reporting a position in DMAC · Health Care. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.

Reported Holders
9
13F filers
Aggregate Value
$1.5M
Across holders
Last Price
$6.55
2026-06-26
Sector
Health Care
GICS
Holder activity7 new1 added1 reduced
Institutional Holders of DMAC
9 holders
ManagerTypeSharesMarket Value% of Total% of PortfolioActionQoQ ChangeQuarter
ExodusPoint Capital Management, LP
CIK 0001736225
Hedge Fund60K$406K26.4%0.0%NewQ1 2026
RENAISSANCE TECHNOLOGIES LLC
CIK 0001037389
Hedge Fund53K$356K23.1%0.0%NewQ1 2026
MARSHALL WACE, LLP
CIK 0001318757
Hedge Fund32K$256K16.7%0.0%NewQ4 2025
BALYASNY ASSET MANAGEMENT LLC
CIK 0001218710
Hedge Fund17K$136K8.8%0.0%NewQ4 2025
Man Group plc
CIK 0001637460
Hedge Fund19K$133K8.7%0.0%NewQ3 2025
Brevan Howard Capital Management LP
CIK 0001512857
Hedge Fund14K$97K6.3%0.0%NewQ1 2026
CITADEL ADVISORS LLC
CIK 0001423053
Hedge Fund12K$81K5.2%0.0%Reduced$-7KQ1 2026
Qube Research & Technologies Ltd
CIK 0001729829
Hedge Fund11K$74K4.8%0.0%NewQ1 2026
AQR CAPITAL MANAGEMENT LLC
CIK 0001167557
Hedge Fund11$740.0%0.0%Added+$20Q1 2026
DMAC Institutional & Hedge Fund Ownership | HedgeFundIntel